Are Ultra-High Drug Prices Sustainable?

1 min read

Goodrx (NASDAQ: GDRX) recently released its list of the 10 most expensive drugs on the market. Novartis(NYSE: NVS) gene therapy Zolgensma remains at the top, but newcomers Eiger Pharmaceuticals (NASDAQ: EIGR) and Y-mAbs Therapeutics (NASDAQ: YMAB) took second and third place with Zokinvy and Danyelza, respectively. In this video from Motley Fool Live, recorded on March 15, Fool.com Contributors Brian Orelli and Keith Speights discuss the high-priced drugs and whether the prices are sustainable in the long run.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Forget Dogecoin, These 3 Tech Stocks Are Better Buys Right Now

Next Story

Our April Fool’s Day Gift to You

Latest from Blog